Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Good Old Fashion Tree Shake

<< Previous

Bullboard Posts

Next >>

Comment by clubhouse19on Dec 17, 2020 11:25am

113 Views

Post# 32128199

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Good Old Fashion Tree Shake

You are too funny...that's what i call hyper fantasy thinking and down 5% per day is nothing according to you
Sounds like you are trying to convince yourself more than anyone else

Actuarial wrote: Down is kind of gradual (at most 5% in a day) with no news but up would be very steep (so often over 100% in a day) should we hear great news. In a Bio industry, either you hear nothing, or, you hear something big. In ATE case, something big can only be positive as ATE has already passed the most risky PhII.

Doccole wrote:
I agree. There is something on the horizon. I view this as a buying opportunity. I continue to add.

yesterday was down, but so was volume. It can bounce up as fast as it can down.